Operating
Share of Profits (Losses) of Related Party
Elevance Health Share of Profits (Losses) of Related Party increased by 107.5% to $305.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 142.1%, from $126.00M to $305.00M. Over 2 years (FY 2021 to FY 2025), Share of Profits (Losses) of Related Party shows a downward trend with a -15.8% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2019
Last reportedQ1 2026Apr 22, 2026
Metric ID:
amgn_equity_method_investment_earningsHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $201.00M | $128.00M | $125.00M | $153.00M | $105.00M | $46.00M | $0.00 | -$30.00M | -$43.00M | -$27.00M | $16.00M | $126.00M | $12.00M | $113.00M | $147.00M | $305.00M |
| QoQ Change | — | -36.3% | -2.3% | +22.4% | -31.4% | -56.2% | -100.0% | — | -43.3% | +37.2% | +159.3% | +687.5% | -90.5% | +841.7% | +30.1% | +107.5% |
| YoY Change | — | — | — | — | -47.8% | -64.1% | -100.0% | -119.6% | -141.0% | +10.0% | — | +566.7% | — | — | +818.8% | +142.1% |
Range-$43.00M – $305.00M
CAGR+11.8%
Avg YoY Growth+118.3%
Median YoY Growth-47.8%
Current Streak3 quarters growth
Share of Profits (Losses) of Related Party at Other Companies
Frequently Asked Questions
- What is Elevance Health's share of profits (losses) of related party?
- Elevance Health (ELV) reported share of profits (losses) of related party of $305.00M in Q1 2026.
- How has Elevance Health's share of profits (losses) of related party changed year-over-year?
- Elevance Health's share of profits (losses) of related party increased by 142.1% year-over-year, from $126.00M to $305.00M.
- What is the long-term trend for Elevance Health's share of profits (losses) of related party?
- Over 2 years (2021 to 2025), Elevance Health's share of profits (losses) of related party has grown at a -15.8% compound annual growth rate (CAGR), from $562.00M to $398.00M.